Literature DB >> 29504956

Hypoxia and the Prolyl Hydroxylase Inhibitor FG-4592 Protect Corneal Endothelial Cells From Mechanical and Perioperative Surgical Stress.

Yogesh Bhadange1,2,3, Jeferson Lautert1,2, Shimin Li4, Edward Lawando4, Edward T Kim4, Mark C Soper5, Francis W Price2, Marianne O Price1, Joseph A Bonanno4.   

Abstract

PURPOSE: To determine whether hypoxia preconditioning can protect corneal endothelial cells from mechanical stress and perioperative procedures mimicking Descemet stripping automated endothelial keratoplasty (DSAEK).
METHODS: Preconditioning was delivered by 2 hours of 0.5% oxygen incubation in a hypoxia chamber or by exposure to the prolyl hydroxylase inhibitor FG-4592, which prevents hypoxia-inducible factor-1 alpha degradation. Damage to whole corneas was produced by brief sonication. To mimic use with DSAEK, FG-4592-preconditioned and control donor corneas were dissected with a microkeratome, and the posterior donor button was pulled through a transplant insertion device (Busin glide). The area of endothelial damage was determined by trypan blue staining.
RESULTS: In all cases, hypoxia preconditioning or incubation with FG-4592 protected corneal endothelial cells from death by mechanical stress. Hypoxia-preconditioned human and rabbit corneas showed 19% and 29% less cell loss, respectively, relative to controls, which were both significant at P < 0.05. FG-4592 preconditioning reduced endothelial cell loss associated with preparation and insertion of DSAEK grafts by 23% relative to the control (P < 0.01).
CONCLUSIONS: These results support the hypothesis that preconditioning by hypoxia or exposure to FG-4592 improves corneal endothelial cell survival and may also provide protection during surgical trauma.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29504956      PMCID: PMC5841548          DOI: 10.1097/ICO.0000000000001430

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  32 in total

1.  Descemet's stripping endothelial keratoplasty five-year graft survival and endothelial cell loss.

Authors:  Marianne O Price; Kelly M Fairchild; David A Price; Francis W Price
Journal:  Ophthalmology       Date:  2010-10-29       Impact factor: 12.079

2.  Posterior lamellar keratoplasty: DLEK to DSEK to DMEK.

Authors:  Gerrit R J Melles
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

3.  Ischemic tolerance in the brain.

Authors:  J Chen; R Simon
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

Review 4.  Cell-based approach for treatment of corneal endothelial dysfunction.

Authors:  Naoki Okumura; Shigeru Kinoshita; Noriko Koizumi
Journal:  Cornea       Date:  2014-11       Impact factor: 2.651

5.  Apoptosis in the endothelium of human corneas for transplantation.

Authors:  J Albon; A B Tullo; S Aktar; M E Boulton
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

6.  Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin.

Authors:  Jing Liu; Purnima Narasimhan; Fengshan Yu; Pak H Chan
Journal:  Stroke       Date:  2005-05-12       Impact factor: 7.914

7.  Deferroxamine preconditioning promotes long-lasting retinal ischemic tolerance.

Authors:  Yanli Zhu; Lihong Zhang; Jeffrey M Gidday
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

Review 8.  The role of calcium in hypoxia-induced signal transduction and gene expression.

Authors:  Karen A Seta; Yong Yuan; Zachary Spicer; Gang Lu; James Bedard; Tsuneo K Ferguson; Peterson Pathrose; Allyson Cole-Strauss; Alexa Kaufhold; David E Millhorn
Journal:  Cell Calcium       Date:  2004 Sep-Oct       Impact factor: 6.817

Review 9.  A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat.

Authors:  Kimberly Becker; Maha Saad
Journal:  Adv Ther       Date:  2017-03-13       Impact factor: 3.845

10.  Telomerase immortalization of human corneal endothelial cells yields functional hexagonal monolayers.

Authors:  Thore Schmedt; Yuming Chen; Tracy T Nguyen; Shimin Li; Joseph A Bonanno; Ula V Jurkunas
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more
  4 in total

1.  The Role of Hypoxia in Corneal Extracellular Matrix Deposition and Cell Motility.

Authors:  Obianamma E Onochie; Anwuli J Onyejose; Celeste B Rich; Vickery Trinkaus-Randall
Journal:  Anat Rec (Hoboken)       Date:  2019-04-05       Impact factor: 2.064

Review 2.  Hypoxia adaptation in the cornea: Current animal models and underlying mechanisms.

Authors:  Kunpeng Pang; Anton Lennikov; Menglu Yang
Journal:  Animal Model Exp Med       Date:  2021-11-28

Review 3.  Clinical Potential of Hypoxia Inducible Factors Prolyl Hydroxylase Inhibitors in Treating Nonanemic Diseases.

Authors:  Mengqiu Miao; Mengqiu Wu; Yuting Li; Lingge Zhang; Qianqian Jin; Jiaojiao Fan; Xinyue Xu; Ran Gu; Haiping Hao; Aihua Zhang; Zhanjun Jia
Journal:  Front Pharmacol       Date:  2022-02-24       Impact factor: 5.810

4.  The Role of Hypoxia-Inducible Factor 1α in the Regulation of Human Meibomian Gland Epithelial Cells.

Authors:  Yang Liu; Jingyi Wang; Di Chen; Wendy R Kam; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-03-09       Impact factor: 4.799

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.